Home › Funds › Sofinnova Investments, Inc. › ANAB

Sofinnova Investments, Inc. position in ANAB

ANAPTYSBIO INC · Health Care

Sofinnova Investments, Inc. reported holding 330,396 shares of ANAB (ANAPTYSBIO INC) in its Q3 2026 13F filing — a position valued at US$16.6M, representing 0.75% of its reported portfolio and ranking #28 among its reported holdings. Sofinnova Investments, Inc. has disclosed ANAB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)330.40K sh
Reported value held$16.61M
Portfolio Weight0.75%
First reportedQ4 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s ANAB position evolved

Sofinnova Investments, Inc. first disclosed a stake in ANAB in Q4 2024 at 132,927 shares (US$1.8M). The position peaked in Q2 2026 at 493,536 shares, worth US$33.3M. Across 8 filings, Sofinnova Investments, Inc. increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 330,396 shares valued at US$16.6M — a reduction of -163,140 shares quarter over quarter.. Notable position changes include a 773% increase in Q1 2025 (shares rose 19% over the following quarter), a 75% trim in Q3 2025 (shares rose 58% over the following quarter), a 99% increase in Q2 2026 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 132.93K $1.76M New
Q1 2025 1.16M $21.57M Add
Q2 2025 1.03M $22.92M Reduce
Q3 2025 254.27K $7.79M Reduce
Q4 2025 287.69K $13.95M Add
Q1 2026 248.25K $13.77M Reduce
Q2 2026 493.54K $33.31M Add
Q3 2026 330.40K $16.61M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANAB and 13F data

ANAB (ANAPTYSBIO INC) is a Health Care company. 34 other funds we track also report a position in ANAB — the largest reported positions include EcoR1 Capital, LLC (US$396.1M), TANG CAPITAL MANAGEMENT LLC (US$89.8M), Sanofi (US$41.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANAB

All ANAB fund holders →

FAQ

How long has Sofinnova Investments, Inc. held ANAB?

Sofinnova Investments, Inc. has disclosed ANAB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Sofinnova Investments, Inc.'s current position in ANAB?

As of Q3 2026, Sofinnova Investments, Inc. holds 330.40K shares of ANAB (ANAPTYSBIO INC), valued at $16.61M, representing 0.75% of its reported portfolio and ranking #28.

Has Sofinnova Investments, Inc. been buying or selling ANAB?

In the latest 13F filing (Q3 2026), Sofinnova Investments, Inc. reduced its position in ANAB. The position peaked in Q2 2026 at 493.54K shares.

Which other funds hold ANAB?

Other major institutional holders of ANAB include EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Sanofi, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.